{{Rsnum
|rsid=4148298
|Gene=UGT2A1
|Chromosome=4
|position=69598983
|Orientation=minus
|GMAF=0.2374
|Gene_s=UGT2A1,UGT2A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 4.5 | 41.4 | 54.1
| HCB | 2.2 | 31.9 | 65.9
| JPT | 0.9 | 30.1 | 69.0
| YRI | 16.0 | 46.5 | 37.5
| ASW | 5.4 | 42.9 | 51.8
| CHB | 2.2 | 31.9 | 65.9
| CHD | 3.7 | 23.4 | 72.9
| GIH | 7.0 | 37.0 | 56.0
| LWK | 12.8 | 39.4 | 47.7
| MEX | 1.7 | 39.7 | 58.6
| MKK | 3.2 | 34.4 | 62.3
| TSI | 6.9 | 27.7 | 65.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24593735
|Title=Pilot study demonstrating potential association between breast cancer image-based risk phenotypes and genomic biomarkers
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}